FDA NDC Directory · JSON-LD · Markdown

PREVDUO

NDC 42023-269 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameneostigmine methylsulfate and glycopyrrolate
Labeler / ManufacturerEndo USA
Marketing categoryNew Drug Application (innovator) · App NDA216903
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsGLYCOPYRROLATE (.2 mg/mL)
NEOSTIGMINE METHYLSULFATE (1 mg/mL)
Marketing started20230515
Package count1

External sources

Source: openFDA. Public-domain (CC0).